Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 820

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs

Open access
Tenev, Tencho, Bianchi, Katiuscia, Darding, Maurice, Broemer, Meike, Langlais, Claudia, Wallberg, Fredrik, Zachariou, Anna, Lopez, Juanita, MacFarlane, Marion, Cain, Kelvin, Meier, Pascal·2011·Molecular Cell
DOI 10.1016/j.molcel.2011.06.006
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2011.06.006

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 50

  1. Berghe, 2010, Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features, Cell Death Differ., 17, 922, 10.1038/cdd.2009.184 · DOI · Paper page
  2. Bertrand, 2008, cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination, Mol. Cell, 30, 689, 10.1016/j.molcel.2008.05.014 · DOI · Paper page
  3. Bianchi, 2009, A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling, Mol. Cell, 36, 736, 10.1016/j.molcel.2009.11.029 · DOI
  4. Biton, 2011, NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling, Cell, 145, 92, 10.1016/j.cell.2011.02.023 · DOI · Paper page
  5. Boatright, 2004, Activation of caspases-8 and -10 by FLIP(L), Biochem. J., 382, 651, 10.1042/BJ20040809 · DOI
  6. Cain, 2000, Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes, J. Biol. Chem., 275, 6067, 10.1074/jbc.275.9.6067 · DOI · Paper page
  7. Cain, 2001, Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome, J. Biol. Chem., 276, 41985, 10.1074/jbc.M107419200 · DOI
  8. Chen, 2009, Smac mimetics as new cancer therapeutics, Anticancer Drugs, 20, 646, 10.1097/CAD.0b013e32832ced78 · DOI
  9. Cheung, 2009, Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound, Cancer Res., 69, 7729, 10.1158/0008-5472.CAN-09-1794 · DOI
  10. Darding, 2011, Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2, Cell Death Differ., 10.1038/cdd.2011.10 · DOI
  11. Ditzel, 2008, Inactivation of effector caspases through nondegradative polyubiquitylation, Mol. Cell, 32, 540, 10.1016/j.molcel.2008.09.025 · DOI
  12. Eckelman, 2006, Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family, EMBO Rep., 7, 988, 10.1038/sj.embor.7400795 · DOI · Paper page
  13. Fandy, 2008, Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells, Mol. Cancer, 7, 60, 10.1186/1476-4598-7-60 · DOI
  14. Feoktistova, 2011, cIAPs block Ripoptosome formation, a RIP1/caspase-8-containing intracellular cell death complex differentially regulated by cFLIP isoforms, Mol. Cell, 43, 449, 10.1016/j.molcel.2011.06.011 · DOI · Paper page
  15. Ferreira, 2000, Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460, Cancer Res., 60, 7133
  16. Gaither, 2007, A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling, Cancer Res., 67, 11493, 10.1158/0008-5472.CAN-07-5173 · DOI
  17. Ganten, 2004, Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs, Cell Death Differ., 11, S86, 10.1038/sj.cdd.4401437 · DOI
  18. Gerl, 2005, Apoptosis in the development and treatment of cancer, Carcinogenesis, 26, 263, 10.1093/carcin/bgh283 · DOI · Paper page
  19. Geserick, 2009, Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment, J. Cell Biol., 187, 1037, 10.1083/jcb.200904158 · DOI
  20. Gyrd-Hansen, 2010, IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer, Nat. Rev. Cancer, 10, 561, 10.1038/nrc2889 · DOI · Paper page
  21. Gyrd-Hansen, 2008, IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis, Nat. Cell Biol., 10, 1309, 10.1038/ncb1789 · DOI · Paper page
  22. Haas, 2009, Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction, Mol. Cell, 36, 831, 10.1016/j.molcel.2009.10.013 · DOI · Paper page
  23. Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  24. Kataoka, 2004, N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway, Mol. Cell. Biol., 24, 2627, 10.1128/MCB.24.7.2627-2636.2004 · DOI
  25. Keane, 1996, Fas expression and function in normal and malignant breast cell lines, Cancer Res., 56, 4791
  26. LaCasse, 1998, The inhibitors of apoptosis (IAPs) and their emerging role in cancer, Oncogene, 17, 3247, 10.1038/sj.onc.1202569 · DOI · Paper page
  27. Legler, 2003, Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation, Immunity, 18, 655, 10.1016/S1074-7613(03)00092-X · DOI · Paper page
  28. Lopez, 2011, CARD-Mediated Autoinhibition of cIAP1's E3 Ligase Activity Suppresses Cell Proliferation and Migration, Mol. Cell, 42, 569, 10.1016/j.molcel.2011.04.008 · DOI
  29. Meier, 2007, Lucifer's labyrinth—ten years of path finding in cell death, Mol. Cell, 28, 746, 10.1016/j.molcel.2007.11.016 · DOI
  30. Micheau, 2002, The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex, J. Biol. Chem., 277, 45162, 10.1074/jbc.M206882200 · DOI · Paper page
  31. Muzio, 1997, FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens, J. Biol. Chem., 272, 2952, 10.1074/jbc.272.5.2952 · DOI · Paper page
  32. Petersen, 2007, Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis, Cancer Cell, 12, 445, 10.1016/j.ccr.2007.08.029 · DOI · Paper page
  33. Pop, 2011, FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity, Biochem. J., 433, 447, 10.1042/BJ20101738 · DOI
  34. Rodriguez, 1999, SUMO-1 modification activates the transcriptional response of p53, EMBO J., 18, 6455, 10.1093/emboj/18.22.6455 · DOI · Paper page
  35. Ryan, 2002, Inhibitor specificity of recombinant and endogenous caspase-9, Biochem. J., 366, 595, 10.1042/bj20020863 · DOI
  36. Song, 2003, Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells, Clin. Cancer Res., 9, 4255
  37. Stagni, 2010, ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and TRAIL-induced apoptosis, Carcinogenesis, 31, 1956, 10.1093/carcin/bgq193 · DOI
  38. Verbrugge, 2010, Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation, Cell Death Differ., 17, 551, 10.1038/cdd.2009.141 · DOI
  39. Vercammen, 1998, Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor, J. Exp. Med., 187, 1477, 10.1084/jem.187.9.1477 · DOI · Paper page
  40. Vince, 2007, IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis, Cell, 131, 682, 10.1016/j.cell.2007.10.037 · DOI · Paper page
  41. Vince, 2009, TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-kappab and to prevent tnf-induced apoptosis, J. Biol. Chem., 284, 35906, 10.1074/jbc.M109.072256 · DOI
  42. Wang, 2008, TNF-alpha induces two distinct caspase-8 activation pathways, Cell, 133, 693, 10.1016/j.cell.2008.03.036 · DOI · Paper page
  43. Wilson, 2009, Death receptor signal transducers: nodes of coordination in immune signaling networks, Nat. Immunol., 10, 348, 10.1038/ni.1714 · DOI · Paper page
  44. Wong, 2010, RIPK1 is not essential for TNFR1-induced activation of NF-kappaB, Cell Death Differ., 17, 482, 10.1038/cdd.2009.178 · DOI
  45. Wu, 2010, TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion, Br. J. Cancer, 102, 639, 10.1038/sj.bjc.6605530 · DOI · Paper page
  46. Wu, 2010, ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress, Mol. Cell, 40, 75, 10.1016/j.molcel.2010.09.010 · DOI
  47. Wu, 2011, zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFα mediated by the PKC-MAPKs-AP-1 pathway, Cell Death Differ., 18, 26, 10.1038/cdd.2010.72 · DOI
  48. Yan, 2009, Expression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alpha, Breast Cancer Res. Treat., 116, 91, 10.1007/s10549-008-0111-5 · DOI
  49. Yang, 2000, Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli, Science, 288, 874, 10.1126/science.288.5467.874 · DOI · Paper page
  50. Zhou, 2000, Viral caspase inhibitors CrmA and p35, Methods Enzymol., 322, 143, 10.1016/S0076-6879(00)22014-4 · DOI

Cited by

Metadata

Authors
Tenev, T., Bianchi, K., Darding, M., Broemer, M., Langlais, C., Wallberg, F., Zachariou, A., Lopez, J., MacFarlane, M., Cain, K., & Meier, P.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2011-08
Volume
43
Issue
3
Pages
432-448
ISSN
1097-2765 (ISSN-L)
DOI
10.1016/j.molcel.2011.06.006
OpenAlex
W2088573055
Cited by
820
References
16
FWCI
28.92
Type
journal article
Language
en
Update notices
erratum (2011-08-19)
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.